FDA announces fast track approval of new drug for lung cancer.
Dyer
Owen
O
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib